4 articles tagged with "Pharmaceuticals"
The Supreme Court has determined that generic pharmaceutical manufacturers cannot be held liable for the prescribing decisions made by pharmacists, a ruling that may reshape accountability in the industry.
BioMarin's innovative pipeline may lead to significant stock growth by 2030, focusing on therapies for rare genetic diseases.
Replimune is set to make a third attempt for FDA approval of its drug, while Pfizer has recently secured a deal in China, highlighting ongoing developments in the pharmaceutical sector.
Biogen and Denali's experimental treatment for Parkinson's disease has not achieved its trial objectives, while Merck's lung cancer therapy appears to offer potential benefits.